Apable, Rinavie .
HRN: 26-43-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2025
CEFUROXIME 500MG (TAB)
04/12/2025
04/18/2025
PO
500mg
Bid
Post Cs
Waiting Final Action
04/11/2025
CEFUROXIME 1.5GM (VIAL)
04/11/2025
04/12/2025
IV
1.5g
Q8
Post Cs
Waiting Final Action
04/12/2025
METRONIDAZOLE 500MG (TAB)
04/12/2025
04/13/2025
IV
500
TID
SP LTCS
Waiting Final Action